4.7 Review

Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis

Journal

SCIENTIFIC REPORTS
Volume 8, Issue -, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-018-21226-y

Keywords

-

Funding

  1. North Staffordshire Medical Institute, Stoke-on-Trent, Staffordshire, UK

Ask authors/readers for more resources

Both overhydration and comorbidity predict mortality in end-stage kidney failure (ESKF) but it is not clear whether these are independent of one another. We undertook a systematic review of studies reporting outcomes in adult dialysis patients in which comorbidity and overhydration, quantified by whole body bioimpedance (BI), were reported. PubMed, EMBASE, PsychInfo and the Cochrane trial database were searched (1990-2017). Independent reviewers appraised studies including methodological quality (assessed using QUIPS). Primary outcome was mortality, with secondary outcomes including hospitalisation and cardiovascular events. Of 4028 citations identified, 46 matched inclusion criteria (42 cohorts; 60790 patients; 8187 deaths; 95% haemodialysis/5% peritoneal dialysis). BI measures included phase angle/BI vector (41%), overhydration index (39%) and extra: intracellular water ratio (20%). 38 of 42 cohorts had multivariable survival analyses (MVSA) adjusting for age (92%), gender (66%), diabetes (63%), albumin (58%), inflammation (CRP/IL6-37%), non-BI nutritional markers (24%) and echocardiographic data (8%). BI-defined overhydration (BI-OH) independently predicted mortality in 32 observational cohorts. Meta-analysis revealed overhydration > 15% (HR 2.28, 95% CI 1.56-3.34, P < 0.001) and a 1-degree decrease in phase angle (HR 1.74, 95% CI 1.37-2.21, P < 0.001) predicted mortality. BI-OH predicts mortality in dialysis patients independent of the influence of comorbidity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

How do patients and their family members experience the transition from peritoneal dialysis to incentre haemodialysis? A multisite qualitative study in England and Australia

Kerry Allen, Sarah L. Damery, Kim Sein, David W. Johnson, Simon J. Davies, Mark Lambie, Els Holvoet, Gill M. Combes

Summary: This study aimed to understand the transition experience and perceptions of patients and caregivers from peritoneal dialysis (PD) to haemodialysis (HD). The findings suggest that while each transition is unique, there are common themes such as resistance to change, importance of family support, and bodily adjustment that affect the transition. Expert support during the transition and providing information about potential treatment options could optimize the process.

PERITONEAL DIALYSIS INTERNATIONAL (2022)

Review Urology & Nephrology

Outcome measures for technique survival reported in peritoneal dialysis: A systematic review

Emma Elphick, Matthew Holmes, Matthew Tabinor, Yeoungjee Cho, Thu Nguyen, Tess Harris, Angela Yee Moon Wang, Arsh K. Jain, Daniela Ponce, Josephine S. F. Chow, Annie-Claire Nadeau-Fredette, Adrian Liew, Neil Boudville, Allison Tong, David W. Johnson, Simon J. Davies, Jeffrey Perl, Karine E. Manera, Mark Lambie

Summary: The study found substantial heterogeneity in how PD technique survival is defined and measured in different studies of patients receiving peritoneal dialysis, leading to considerable variability in reported rates. Standardised measures are needed to improve comparability in PD studies.

PERITONEAL DIALYSIS INTERNATIONAL (2022)

Article Medicine, General & Internal

Widening access to the specialised foundation programme

Sofian Youssef, Syed Zaidi, Mark Lambie, Shahzada Ahmed

Summary: This article provides frameworks to simplify the challenges of the specialised foundation programme application process and interviews for doctors interested in research, medical education, and leadership.

BRITISH JOURNAL OF HOSPITAL MEDICINE (2022)

Article Urology & Nephrology

Variation in Peritoneal Dialysis Time on Therapy by Country Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study

Mark Lambie, Junhui Zhao, Keith McCullough, Simon J. Davies, Hideki Kawanishi, David W. Johnson, James A. Sloand, Mauricio Sanabria, Talerngsak Kanjanabuch, Yong-Lim Kim, Jenny I. Shen, Ronald L. Pisoni, Bruce M. Robinson, Jeffrey Perl, PDOPPS Steering Comm

Summary: This study analyzes data from a multinational observational study to demonstrate the relationship between time on peritoneal dialysis and outcomes such as transfer to hemodialysis, death, and kidney transplantation. The study finds that countries with higher rates of kidney transplantation tend to have shorter median times on peritoneal dialysis, and infection is the leading cause of hemodialysis transfer.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Review Endocrinology & Metabolism

Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022

Andrew H. Frankel, Mona Wahba, Vicky Ashworth, Rachna Bedi, Rachel Berrington, Maria Buckley, Lakshmi Chandrasekharan, Fiona Doyle, Deborah Duval, Frances Game, Susie Hamilton, Sufyan Hussain, June James, Hannah Jebb, Janaka Karalliedde, Marie-France Kong, Apexa Kuverji, Mark Lambie, Claire Main, Sara Price, Piyumi Wijewickrama, Jennifer Williams, Ketan Dhatariya, Tahseen A. Chowdhury

Summary: Diabetes is the leading cause of end-stage kidney disease worldwide, and its complications pose challenges for people on dialysis. The updated guidance from the Joint British Diabetes Societies focuses on glycaemic monitoring and covers clinical issues related to diabetes management in people on peritoneal dialysis, as well as acute and chronic complications.

DIABETIC MEDICINE (2023)

Article Urology & Nephrology

IMPROVE-PD Finder: A Web-Based Platform to Search and Share Peritoneal Dialysis Biobank, Registry, and Clinical Trial Metadata

Ivan Damgov, Maria Bartosova, Iva Marinovic, Obaida Istanbuly, Meinhard Kieser, Mark Lambie, Simon J. Davies, Claus Peter Schmitt

KIDNEY INTERNATIONAL REPORTS (2023)

Article Urology & Nephrology

Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial

Simon J. Davies, David Coyle, Elizabeth J. Lindley, David Keane, John Belcher, Fergus J. Caskey, Indranil Dasgupta, Andrew Davenport, Ken Farrington, Sandip Mitra, Paula Ormandy, Martin Wilkie, Jamie MacDonald, Mandana Zanganeh, Lazaros Andronis, Ivonne Solis-Trapala, Julius Sim

Summary: Avoiding excessive dialysis-associated volume depletion may help preserve residual kidney function. A randomized controlled trial was conducted to examine whether knowledge of estimated normally hydrated weight could reduce the rate of loss of residual kidney function. The results showed that using a standardized clinical protocol for fluid assessment can effectively preserve residual kidney function without the need for bioimpedance measurements.

KIDNEY INTERNATIONAL (2023)

Review Urology & Nephrology

Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis

Piyumi Wijewickrama, Jennifer Williams, Steve Bain, Indranil Dasgupta, Tahseen A. Chowdhury, Mona Wahba, Andrew H. Frankel, Mark Lambie, Janaka Karalliedde

Summary: There is a lack of guidelines for managing glucose control in people with diabetes on peritoneal dialysis (PD). Therefore, a summarized review of relevant literature was conducted, focusing on individualized care, burden of hypo-glycemia, glycemic variability, and treatment choices for optimizing glucose control in this population. The lack of sufficient and suitable clinical studies limited the ability to conduct a formal systematic review, but available evidence was reviewed to provide guidance.

KIDNEY INTERNATIONAL REPORTS (2023)

Article Urology & Nephrology

The Peritoneal Membrane and Its Role in Peritoneal Dialysis

Johann Morelle, Mark Lambie, Carl M. Oberg, Simon Davies

Summary: A healthy peritoneal membrane is crucial for effective peritoneal dialysis treatment. Variability and dysfunction of the membrane can lead to fluid overload and complications. This review provides an overview of the structure, function, and pathophysiology of the peritoneal membrane and discusses their clinical implications for patient-centered care.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Microbiology

The Impact of Antimicrobial Resistance on Outcomes for Patients Undergoing Coronary Artery Bypass Graft and Valve Surgery: A Retrospective Cohort Study of Hospital Admissions Data from the National Inpatient Sample

Kirellos Abbas Said, Maximillian Will, Adnan I. Qureshi, Chun Shing Kwok

Summary: A retrospective cohort study using data from the National Inpatient Sample in the United States was conducted to evaluate the proportion of patients undergoing cardiac surgery who had antimicrobial resistance. The study found that patients with antimicrobial resistance were more likely to be female and had a higher in-hospital mortality rate. Antimicrobial resistance significantly increased the length of stay and cost for patients.

MICROBIOLOGY RESEARCH (2023)

Article Urology & Nephrology

Volume Management in Hemodialysis-A Moving Target

Simon J. Davies

KIDNEY360 (2023)

Article Urology & Nephrology

International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival

Simon J. Davies, Junhui Zhao, Keith P. McCullough, Yong-Lim Kim, Angela Yee-Moon Wang, Sunil Badve, Rajnish Mehrotra, Talerngsak Kanjanabuch, Hideki Kawanishi, Bruce M. Robinson, Ronald Pisoni, Jeffrey Perl

Summary: There are significant differences in the prescription of icodextrin internationally, with the United States using it less frequently. Icodextrin prescription is associated with hypertonic glucose avoidance and equivalent ultrafiltration, but not with mortality or permanent transfer to hemodialysis.

KIDNEY360 (2022)

No Data Available